Growth Metrics

Innoviva (INVA) Operating Margin Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 530.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,211.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,993.00
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn 146,431.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 146,431.00
Dec 31, 2025 -29,133.00
Sep 30, 2025 3,169.00
Jun 30, 2025 53,826.00
Mar 31, 2025 75,669.00
Dec 31, 2024 -24,183.00
Sep 30, 2024 -4,831.00
Jun 30, 2024 -821,067.00
Mar 31, 2024 -54,895.00
Dec 31, 2023 84,986.00
Sep 30, 2023 3,260.00
Jun 30, 2023 -107,855.00
Mar 31, 2023 -152,212.00
Dec 31, 2022 -107,961.00
Sep 30, 2022 -9,207.00
Jun 30, 2022 -58,286.00
Mar 31, 2022 -80,449.00
Dec 31, 2021 -70,822.00
Sep 30, 2021 313.00
Jun 30, 2021 817,199.00
Mar 31, 2021 -58,754.00
Dec 31, 2020 -137,588.00
Sep 30, 2020 1,292.00
Jun 30, 2020 1,433.00
Mar 31, 2020 2,428.00
Dec 31, 2019 1,058.00
Sep 30, 2019 864.00
Jun 30, 2019 1,353.00
Mar 31, 2019 2,202.00
Dec 31, 2018 2,097.00
Sep 30, 2018 3,130.00
Jun 30, 2018 4,548.00
Mar 31, 2018 6,689.00
Dec 31, 2017 9,374.00
Sep 30, 2017 103,743.00
Jun 30, 2017 113,028.00
Mar 31, 2017 196,003.00
Dec 31, 2016 58,988.00
Sep 30, 2016 194,092.00
Jun 30, 2016 60,148.00
Mar 31, 2016 259,801.00
Dec 31, 2015 4,185.00
Sep 30, 2015 239,436.00
Jun 30, 2015 687,566.00
Mar 31, 2015 -5,759.00
Dec 31, 2014 66,525.00
Sep 30, 2014 -50,107.00
Jun 30, 2014 -67,833.00
Mar 31, 2014 -155,109.00